Intravascular laser irradiation of blood (ILIB) used to treat lung diseases: a short critical review

Abstract Intravascular laser irradiation of blood (ILIB) was developed to treat cardiovascular diseases due to its rheological effects. In its original form, ILIB was applied by an intravenous optical fiber, restricting its application. However, this technique was modified to non-invasive irradiation through the radial artery, now called vascular photobiomodulation (VPBM). Many studies have used both, ILIB and VPBM, to treat lung diseases. It is well established that lung diseases affect more than 300 million people worldwide with high morbidity and mortality rates. In this short critical review, we discuss the potential benefits of photobiomodulation to treat lung diseases using these two approaches. The search was performed in the electronic database of MEDLINE (Medical Literature Analysis and Retrieval System Online) via PubMed. The data search was carried out from 1991 to 2017. We selected a total of 10 clinical studies using either ILIB or VPBM, in addition to 2 experimental studies in animals. The respiratory diseases treated in these studies included bronchitis, asthma, pneumonia, and tuberculosis. The results showed overall beneficial effects on lung diseases, characterized by a reduction in the inflammatory cascade and antioxidant effects, improvement of hemodynamic parameters, the efficiency of gas exchange, and reduction of hospitalization periods. In conclusion, all studies showed promising effects of ILIB in both animal and human studies. The studies did not discuss any disadvantages or contraindications. However, further studies are needed in order to understand the dosimetry, and the literature is lacking in randomized, controlled clinical trials. Thus, this review highlights the need for additional studies using this approach..

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:38

Enthalten in:

Lasers in medical science - 38(2023), 1 vom: 25. März

Sprache:

Englisch

Beteiligte Personen:

Schapochnik, Adriana [VerfasserIn]
Alonso, Paula Tatiane [VerfasserIn]
de Souza, Vanessa [VerfasserIn]
Rodrigues, Virginia [VerfasserIn]
Quintela, Kelly [VerfasserIn]
Cruz, Marlon da Palma [VerfasserIn]
Ferreira, Caroline Marcantonio [VerfasserIn]
Cecatto, Rebeca Boltes [VerfasserIn]
Rodrigues, Maria Fernanda Setubal Destro [VerfasserIn]
Hamblin, Michael R. [VerfasserIn]
Lino-dos-Santos-Franco, Adriana [VerfasserIn]

Links:

Volltext [lizenzpflichtig]

Themen:

Animals
Blood
Humans
ILIB therapy
Lung diseases
Photobiomodulation

Anmerkungen:

© The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

doi:

10.1007/s10103-023-03750-0

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

SPR049829459